Efficacy and Safety of Treating Refractory Bone and Soft Tissue Sarcoma with Anlotinib in Different Treatment Patterns

Figure 6

(a, b) Kaplan–Meier curve of progression-free survival and overall survival for patients with soft tissue sarcoma receiving anlotinib alone and anlotinib plus chemotherapy or radiotherapy.

(a)

(b)